UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 77

Sortiert nach

Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001

Annals of oncology, 2019-04, Vol.30 (4), p.582-588

2019

Link zum Volltext

Verfügbarkeit prüfen

A phase I/Ib study of concurrent intravenous (IV) and intrathecal (IT) nivolumab (Nivo) for melanoma patients (pts) with leptomeningeal disease (LMD)

Annals of oncology, 2018-10, Vol.29, p.viii464-viii464

2018

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of pembrolizumab (Pembro) in patients (Pts) with advanced melanoma with stable brain metastases (BM) at baseline: A pooled retrospective analysis

Annals of oncology, 2018-10, Vol.29, p.viii444-viii444

2018

Link zum Volltext

Verfügbarkeit prüfen

Remote and Local SST Forcing in Shaping Asian-Australian Monsoon Anomalies

Journal of the Meteorological Society of Japan. Ser. II, 2005, Vol.83(2), pp.153-167

2005

Link zum Volltext

Verfügbarkeit prüfen

Safety of reduced infusion times for nivolumab plus ipilimumab (N + I) and nivolumab alone (N) in advanced melanoma

Annals of oncology, 2016-10, Vol.27, p.vi385-vi385

2016

Link zum Volltext

Verfügbarkeit prüfen

P0116 Updated clinical efficacy of the anti-PD-1 monoclonal antibody pembrolizumab (MK-3475) in 411 patients with melanoma

European journal of cancer (1990), 2015-07, Vol.51, p.e24-e24

2015

Link zum Volltext

Verfügbarkeit prüfen

Pembrolizumab (Pembro; Mk-3475) for Advanced Melanoma (Mel): Randomized Comparison of Two Dosing Schedules

Annals of oncology, 2014-09, Vol.25, p.v1

2014

Link zum Volltext

Verfügbarkeit prüfen

Renal cell carcinoma: A paradigm of lanthanic disease

American journal of clinical oncology, 1999-06, Vol.22 (3), p.223-231

1999

Link zum Volltext

Verfügbarkeit prüfen

Risk of intracranial hemorrhage with anticoagulation therapy in melanoma patients with brain metastases

Melanoma research, 2012-08, Vol.22 (4), p.310-315

2012

Link zum Volltext

Verfügbarkeit prüfen

Systemic chemotherapy

Clinics in plastic surgery, 2000-07, Vol.27 (3), p.451

2000

Link zum Volltext

Verfügbarkeit prüfen

1139P Long-term safety profile of pembrolizumab monotherapy and relationship with clinical outcome: A pooled analysis of patients with advanced melanoma

Annals of oncology, 2020-09, Vol.31, p.S762-S763

2020

Link zum Volltext

Verfügbarkeit prüfen

A Phase 1/2 trial of intratumoral (i.t.) IMO-2125 (IMO) in combination with checkpoint inhibitors (CPI) in PD-(L)1-refractory melanoma

Annals of oncology, 2017-09, Vol.28, p.v421-v421

2017

Link zum Volltext

Verfügbarkeit prüfen

The safety of temozolomide in the treatment of malignancies

Expert opinion on drug safety, 2009-07, Vol.8 (4), p.493-499

2009

Link zum Volltext

Verfügbarkeit prüfen

KEYNOTE 029: Phase 1/2 randomized study of pembrolizumab (pembro) plus 2 dose regimens of ipilimumab (ipi) for advanced melanoma

Annals of oncology, 2017-09, Vol.28, p.v446-v446

2017

Link zum Volltext

Verfügbarkeit prüfen

Staging work-up and post-treatment surveillance of patients with melanoma

Clinics in plastic surgery, 2000-07, Vol.27 (3), p.377

2000

Link zum Volltext

Verfügbarkeit prüfen

Survie à 3 ans des patients traités pour mélanome métastatique par prembrolizumab (Keynote-001) et devenir des patients en réponse complète

Annales de dermatologie et de vénéréologie, 2016-12, Vol.143 (12), p.S209-S210

2016

Link zum Volltext

Verfügbarkeit prüfen

Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001

Annals of oncology, 2019-04, Vol.30 (4), p.582

2019

Link zum Volltext

Verfügbarkeit prüfen

Consistent Antibody Response against Ganglioside GD2 Induced in Patients with Melanoma by a GD2 Lactone-Keyhole Limpet Hemocyanin Conjugate Vaccine plus Immunological Adjuvant QS-21

Clinical cancer research, 2003-11, Vol.9 (14), p.5214-5220

2003

Link zum Volltext

Verfügbarkeit prüfen

Management of venous thromboembolism (VTE) in melanoma patients with brain metastasis

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.9522-9522

2008

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic/pharmacodynamic analysis of adjuvant pegylated interferon [alpha]-2b in patients with resected high-risk melanoma

Cancer chemotherapy and pharmacology, 2011-03, Vol.67 (3), p.657

2011

Link zum Volltext

Verfügbarkeit prüfen

Traitement par anticorps anti-PD-1 : pembrolizumab (MK-3475) chez 411 patients (pts) atteints de mélanome métastatique

Annales de dermatologie et de vénéréologie, 2014-12, Vol.141 (12), p.S258-S259

2014

Link zum Volltext

Verfügbarkeit prüfen

1301TiPA phase I/Ib study of concurrent intravenous (IV) and intrathecal (IT) nivolumab (Nivo) for melanoma patients (pts) with leptomeningeal disease (LMD)

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Link zum Volltext

Verfügbarkeit prüfen

1248PDEfficacy of pembrolizumab (Pembro) in patients (Pts) with advanced melanoma with stable brain metastases (BM) at baseline: A pooled retrospective analysis

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Link zum Volltext

Verfügbarkeit prüfen

Molecular dissection of the RAS/RAF/MAPK pathway in primary and metastatic melanoma

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.8050-8050

2006

Link zum Volltext

Verfügbarkeit prüfen

Colonic Melanoma, Primary or Regressed Primary

Journal of clinical gastroenterology, 2000-06, Vol.30 (4), p.441-444

2000

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 77

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieInvestigational New Drugs

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(64)
Mit Volltextzugriff
(70)

Publikationsform

Artikel
(70)
Tagungsberichte
(7)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(42)
Humans
(22)
Life Sciences & Biomedicine
(18)
Technology
(15)
Biological And Medical Sciences
(10)
Exact Sciences And Technology
(10)
Physical Sciences
(9)
Medical Sciences
(8)
Schizophrenia
(8)
Schizophrenia - Genetics
(8)
Computer Science
(7)
Computer Science, Hardware & Architecture
(7)
Engineering
(7)
Engineering, Electrical & Electronic
(7)
Oncology
(7)
Physics
(7)
Melanoma - Pathology
(6)
Animals
(5)
Male
(5)
Neurosciences
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001

A phase I/Ib study of concurrent intravenous (IV) and intrathecal (IT) nivolumab (Nivo) for melanoma patients (pts) with leptomeningeal disease (LMD)

Efficacy of pembrolizumab (Pembro) in patients (Pts) with advanced melanoma with stable brain metastases (BM) at baseline: A pooled retrospective analysis

Remote and Local SST Forcing in Shaping Asian-Australian Monsoon Anomalies

Safety of reduced infusion times for nivolumab plus ipilimumab (N + I) and nivolumab alone (N) in advanced melanoma

P0116 Updated clinical efficacy of the anti-PD-1 monoclonal antibody pembrolizumab (MK-3475) in 411 patients with melanoma

Pembrolizumab (Pembro; Mk-3475) for Advanced Melanoma (Mel): Randomized Comparison of Two Dosing Schedules

Renal cell carcinoma: A paradigm of lanthanic disease

Risk of intracranial hemorrhage with anticoagulation therapy in melanoma patients with brain metastases

Systemic chemotherapy

1139P Long-term safety profile of pembrolizumab monotherapy and relationship with clinical outcome: A pooled analysis of patients with advanced melanoma

A Phase 1/2 trial of intratumoral (i.t.) IMO-2125 (IMO) in combination with checkpoint inhibitors (CPI) in PD-(L)1-refractory melanoma

The safety of temozolomide in the treatment of malignancies

KEYNOTE 029: Phase 1/2 randomized study of pembrolizumab (pembro) plus 2 dose regimens of ipilimumab (ipi) for advanced melanoma

Staging work-up and post-treatment surveillance of patients with melanoma

Survie à 3 ans des patients traités pour mélanome métastatique par prembrolizumab (Keynote-001) et devenir des patients en réponse complète

Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001

Consistent Antibody Response against Ganglioside GD2 Induced in Patients with Melanoma by a GD2 Lactone-Keyhole Limpet Hemocyanin Conjugate Vaccine plus Immunological Adjuvant QS-21

Management of venous thromboembolism (VTE) in melanoma patients with brain metastasis

Pharmacokinetic/pharmacodynamic analysis of adjuvant pegylated interferon [alpha]-2b in patients with resected high-risk melanoma

Traitement par anticorps anti-PD-1 : pembrolizumab (MK-3475) chez 411 patients (pts) atteints de mélanome métastatique

1301TiPA phase I/Ib study of concurrent intravenous (IV) and intrathecal (IT) nivolumab (Nivo) for melanoma patients (pts) with leptomeningeal disease (LMD)

1248PDEfficacy of pembrolizumab (Pembro) in patients (Pts) with advanced melanoma with stable brain metastases (BM) at baseline: A pooled retrospective analysis

Molecular dissection of the RAS/RAF/MAPK pathway in primary and metastatic melanoma

Colonic Melanoma, Primary or Regressed Primary

Aktive Filter

Suchergebnisse filtern